Synonymes : LEVOMENOL|(-)-alpha-Bisabolol|23089-26-1|Kamillosan|alpha-Bisabolol|Bisabolol|alpha-(-)-Bisabolol|Levomenolum|Kamilosan|.alpha.-Bisabolol|1-alpha-Bisabolol|Levomenol [INN]|alpha-Bisabolol, L-|alpha-Bisabolol (-)-form|UNII-24WE03BX2T|24WE03BX2T|CCRIS 9081|(-)-6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol|DTXSID4042094|FEMA NO. 4666|(2S)-6-methyl-2-[(1S)-4-methylcyclohex-3-en-1-yl]hept-5-en-2-ol|(-)-.alpha.-Bisabolol|EINECS 245-423-3|Levomenolum [INN-Latin]|(-)--BISABOLOL|Bisabolol, (-)-.alpha.|.alpha.-bisabolol, (-)-|CHEBI:125|.alpha.-Bisabolol (-)-form|DTXCID2022094|(.alpha.s,1s)-.alpha.-bisabolol|3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (alphaS,1S)-|LEVOMENOL (MART.)|LEVOMENOL [MART.]|3-Cyclohexene-1-methanol, a,4-dimethyl-a-(4-methyl-3-pentenyl)-,(aS,1S)-|LEVOMENOL (USP-RS)|LEVOMENOL [USP-RS]|Dragosantol|Camilol|a-Bisabolol|Hydagen B|((-))-6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol|(S)-6-Methyl-2-((S)-4-methylcyclohex-3-en-1-yl)hept-5-en-2-ol|5-Hepten-2-ol, 6-methyl-2-(4-methyl-3-cyclohexen-1-yl)-, (-)-|3-Cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)-, [S-(R*,R*)]-|3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (S-(theta,theta))-|BISABOLOL, ALPHA|BISABOLOL, .ALPHA.|RACEMIC ALFA-BISABOLOL|515-69-5|Bisbalol|BISABOLA-1,12-DIEN-8-OL|EINECS 208-205-9|EINECS 246-973-7|L-alpha-Bisabolol|Levomenol, INN|(-)-a-Bisabolol|l-.alpha.-Bisabolol|.alpha.-Bisabolol, L-|BISABOLOL [INCI]|(-)- alpha -Bisabolol|.alpha.-(-)-Bisabolol|BISABOLOL [VANDF]|ALPHA-(-)BISABOLOL|LEVOMENOL [WHO-DD]|BISABOLOL, (-)-alpha|SCHEMBL24989|alpha-BISABOLOL, (-)-|(alphaS,1S)-alpha-BISABOLOL|3-Cyclohexene-1-methanol, ?,4-dimethyl-?-(4-methyl-3-pentenyl)-, (R,R)-|CHEMBL1096927|(-)-(4S,8S)-alpha-Bisabolol|(-)-alpha-Bisabolol (Levomenol)|(alpha R,1R)-rel-alpha,4-Dimethyl-alpha-(4-methyl-3-penten-1-yl)-3-cyclohexene-1-methanol|(R*, R*)- a, 4- dimethyl- a- (4- methyl- 3- pentenyl)cyclohex- 3- ene- 1- methanol|(R*,R*)-alpha,4-Dimethyl-alpha-(4-methyl-3-pentenyl)cyclohex-3-ene-1-methanol|(R*,R*) - a,4 - dimethyl - a - (4 - methyl - 3 - pentenyl)cyclohex - 3 - ene - 1 - methanol|3-ciclohexeno-1-metanol, Alfa,4-Dimetil-Alfa-(4-metil-3-penten-1-il)-, (Alfa R, 1R)-rel-|HY-N6967|[S-(R*,R*)]-.alpha.-Bisabolol|Tox21_301375|BDBM50382730|MFCD03412455|NSC782530|Levomenol 100 microg/mL in Methanol|DB13153|LMPR0103060001|NSC-782530|(-)-alpha-Bisabolol, >=93% (GC)|(-)-Alpha-bisabolol(-)-alpha-bisabolol|NCGC00255987-01|(-)-alpha-Bisabolol, analytical standard|.ALPHA.-BISABOLOL (-)-FORM [MI]|CAS-23089-26-1|CS-0028206|Alpha-Bisabolol 1000 microg/mL in Isopropanol|C09621|EN300-19632355|Q179896|J-014978|(-)-alpha-BISABOLOL (CONSTITUENT OF CHAMOMILE)|(-)-alpha-Bisabolol, primary pharmaceutical reference standard|Levomenol, United States Pharmacopeia (USP) Reference Standard|(-)-.ALPHA.-BISABOLOL (CONSTITUENT OF CHAMOMILE) [DSC]|6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol, (-)-|5-HEPTEN-2-OL, 6-METHYL-2-(4- METHYL-3-CYCLOHEXEN-1-YL), (-)-|5-HEPTEN-2-OL, 6-METHYL-2-(4-METHYL-3-CYCLOHEXEN-1-YL), (-)-|[S-(R*,R*)]-.alpha.,4-Dimethyl-.alpha.-(4-methyl-3-pentenyl)cyclohex-3-ene-1-methanol|3-ciclohexeno-1-metanol, ?,4-dimetil-?-(4-metil-3-penten-1-il)-, (?s,1s)-|3-Cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)-, (-)-|3-Cyclohexene-1-methanol, ?,4-dimethyl-?-(4-methyl-3-pentenyl)-, [S-(R,R)]-|3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (.alpha.S,1S)-|3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (S-(R*,R*))-|alpha,4-Dimethyl-alpha-(4-methyl-3-penten-1-yl)-(alphaS,1S)-3-Cyclohexene-1-methanol|3-CYCLOHEXENE-1-METHANOL, .ALPHA.,4-DIMETHYL-.ALPHA.-(4-METHYL-3-PENTEN-1-YL)-, (.ALPHA.S,1S)-|3-CYCLOHEXENE-1-METHANOL, alpha,4-DIMETHYL-alpha-(4-METHYL-3-PENTEN-1-YL)-, (alphaS,1S)-